RESUMO
While the majority of American Academy of Dermatology members have some broad awareness of human trafficking, most are not aware of it in their communities or of the skin signs that could prompt identification of those being exploited, and have requested educational resources to assist patients affected by trafficking. The American Academy of Dermatology Ad Hoc Task Force on Dermatologic Resources for the Intervention and Prevention of Human Trafficking has been working to develop relevant resources, including an online toolkit on the American Academy of Dermatology website: https://www.aad.org/member/clinical-quality/clinical-care/human-trafficking.
Assuntos
Dermatologia , Tráfico de Pessoas , Humanos , Estados Unidos , Comitês Consultivos , Academias e InstitutosRESUMO
INTRODUCTION: Chronic exposure to ultraviolet light photoages skin. Retinol, a precursor molecule to retinoic acid that causes less irritation, is available as a nonprescription, cosmetic retinoid and improves collagen production, skin elasticity, and signs of photoaging. Advances in formulation science have allowed the production of stabilized bioactive retinol formulations. This integrated analysis aims to build on previous studies and further examine the comprehensive efficacy and tolerability of topical 0.1% stabilized bioactive retinol. METHODS: This analysis included 6 vehicle-controlled studies of 0.1% stabilized bioactive retinol in women with mild-to-moderate signs of photodamage. Across all studies, the same dermatologist investigator assessed overall photodamage; wrinkles on the forehead, cheeks, and undereye area; crow’s feet wrinkles and fine lines; lack of even skin tone; and brown spots at baseline and weeks 4, 8, and 12 on a numerical scale. Tolerability was also assessed. RESULTS: Participants (retinol, N=237; vehicle, N=234) had a mean (SD) age of 47.4 (6.6) years. Retinol induced greater improvements from baseline in all signs of photoaging vs vehicle as early as week 4 and through 12 weeks of application. Few participants experienced irritation; all events were mild to moderate and transient. The most common signs of irritation were erythema (n=2) and skin scaling/peeling (n=5). CONCLUSIONS: This pooled analysis of 6 vehicle-controlled clinical studies provides new evidence for the efficacy of 0.1% stabilized bioactive retinol in improving signs of photoaging without causing major irritation. Topical 0.1% stabilized bioactive retinol was well tolerated with only a few reported cases of skin irritation. J Drugs Dermatol. 2024;23(4): doi:10.36849/JDD.8124.
Assuntos
Envelhecimento da Pele , Vitamina A , Feminino , Humanos , Pessoa de Meia-Idade , Administração Cutânea , Método Duplo-Cego , Retinoides , Resultado do Tratamento , Tretinoína/efeitos adversos , Adulto , Ensaios Clínicos Controlados como AssuntoRESUMO
INTRODUCTION: Rosacea is a chronic condition involving inflammation leading to a diminished skin barrier function in sebaceous gland-rich facial skin. The current algorithm represents part II of a series investigating similar topics associated with preventing, treating, and maintaining rosacea, including ceramides-containing skincare. METHODS: The consensus process consisted of a modified Delphi technique. A previously published review by the US Cutaneous Rosacea Outcomes (USCRO) group on skin barrier deficiency in rosacea and the integration of over-the-counter (OTC) products and skincare recommended for rosacea treatment and maintenance informed the development of the current algorithm. The selected information from the literature searches, coupled with the USCRO group's opinion and experience, was used to develop, discuss, and reach a consensus on an evidence-based clinical treatment and maintenance algorithm focusing on rosacea phenotypes. RESULTS: The algorithm includes foundational measures to be taken by all patients with rosacea and rosacea-prone skin. These measures include education, behavioral modifications, avoidance of triggers and skin irritants, preventative skincare, and sun avoidance and sunscreen use. The algorithm further describes how assessment of skin condition and grading of cutaneous rosacea should take place during treatment and maintenance while the preventative measures continue. CONCLUSIONS: Prescription medications combined with gentle cleansers, moisturizers, and sunscreen support a successful rosacea therapy. J Drugs Dermatol. 2022;21:9(Suppl 1):s3-10.
Assuntos
Rosácea , Protetores Solares , Algoritmos , Humanos , Rosácea/diagnóstico , Rosácea/tratamento farmacológico , Pele , Higiene da Pele/métodos , Protetores Solares/uso terapêuticoRESUMO
BACKGROUND: Rosacea, an inflammatory skin disease that leads to an impaired skin barrier function commonly involves the face. Symptoms of rosacea can be bothersome and include pain, stinging, burning, itching, and facial flushing. This review explored skin barrier impairment in rosacea and reduced symptomatology when using over the counter (OTC) skincare products. METHODS: Nine dermatologists (the panel) completed a survey on OTC products they recommend for rosacea. The survey results were summarized, presented, and discussed during the online meeting, together with the results of a literature review. The outcome of these discussions, coupled with the panel's expert opinion and experience, is shown in the current review. RESULTS: Addressing barrier dysfunction by use of moisturizer and cleanser formulations that restore skin hydration, normalize skin pH, restore the microbiome, and skin lipids can assist in improving rosacea signs and symptoms. The panel's consensus was that in addition to the use of prescription medications, skincare recommendations are a crucial part of successful rosacea therapy. In addition to occlusives and humectants, barrier restoring ingredients such as ceramides, hyaluronic acid, and niacinamide were considered beneficial. Equally important was the absence of potentially irritating substances. CONCLUSIONS: The use of OTC products can improve rosacea symptomatology and signs. As adjuncts, these products are recommended before and during prescription therapy and as part of a maintenance regimen. J Drugs Dermatol. 20(4):384-392. doi:10.36849/JDD.5861 THIS ARTICLE HAD BEEN MADE AVAILABLE FREE OF CHARGE. PLEASE SCROLL DOWN TO ACCESS THE FULL fTEXT OF THIS ARTICLE WITHOUT LOGGING IN. NO PURCHASE NECESSARY. PLEASE CONTACT THE PUBLISHER WITH ANY QUESTIONS.
Assuntos
Fármacos Dermatológicos/administração & dosagem , Medicamentos sem Prescrição/administração & dosagem , Medicamentos sob Prescrição/administração & dosagem , Rosácea/terapia , Higiene da Pele/métodos , Administração Cutânea , Terapia Combinada/métodos , Terapia Combinada/normas , Consenso , Dermatologia/métodos , Dermatologia/normas , Humanos , Microbiota/efeitos dos fármacos , Guias de Prática Clínica como Assunto , Rosácea/microbiologia , Rosácea/patologia , Índice de Gravidade de Doença , Pele/efeitos dos fármacos , Pele/microbiologia , Pele/patologia , Higiene da Pele/normas , Resultado do Tratamento , Perda Insensível de Água/efeitos dos fármacosRESUMO
Hand dermatitis is estimated to affect greater than 15% of the general population. Childhood eczema, frequent hand washing, and occupational exposure to chemicals are predisposing factors. Hand dermatitis treatment involves both prevention of outbreaks and treatment of active disease. Moisturizers are essential to protect the skin from the environment, enhance hydration, and repair the skin barrier. They have been shown in large studies to prevent occupational related breakouts. Natural oils are commonly used in moisturizers for their moisturizing and emollient properties. Sweet almond oil is an oil that contains high levels of fatty acids and has been used for centuries to treat skin diseases such as eczema and psoriasis. In this study, a moisturizer with 7% sweet almond oil and 2% colloidal oatmeal was found to be both safe and effective in treating patients with moderate to severe hand dermatitis.
J Drugs Dermatol. 2018;17(1):78-82.
.Assuntos
Dermatite Ocupacional/tratamento farmacológico , Eczema/tratamento farmacológico , Dermatoses da Mão/tratamento farmacológico , Óleos de Plantas/uso terapêutico , Creme para a Pele/uso terapêutico , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Medicamentos sem Prescrição , Satisfação do Paciente , Óleos de Plantas/análise , Creme para a Pele/química , Fenômenos Fisiológicos da Pele/efeitos dos fármacos , Adulto JovemRESUMO
Atopic dermatitis (AD) is well-recognized as a very common chronic and relapsing pruritic skin disorder affecting both children and adults worldwide. The adverse effects on the quality of life of affected individuals and their families is well-established. The pathophysiology of AD is complex, leading to interindividual variations in clinical presentation and severity. The chronicity of AD, characterized by periods of exacerbation and remission, supports a strong need to develop measures that can effectively and safely prolong remissions between flares of the disease. This article provides an overview of AD including prevalence, severity, and disease course/progression, succinct summaries of pathophysiology and medical management, and discussion of epidermal barrier dysfunction and skin microbiome shifting associated with AD. Additional emphasis is placed on adjunctive topical skin barrier approaches that may prolong disease-free remissions. Results from a panel of dermatologists queried about adjunctive approaches to AD, using a modified-Delphi approach, are also discussed. J Drugs Dermatol. 2018;17(10):1070-1076.
THIS ARTICLE HAD BEEN MADE AVAILABLE FREE OF CHARGE.
PLEASE SCROLL DOWN TO ACCESS THE FULL TEXT OF THIS ARTICLE WITHOUT LOGGING IN.
NO PURCHASE NECESSARY.
PLEASE CONTACT THE PUBLISHER WITH ANY QUESTIONS.
.Assuntos
Dermatite Atópica/epidemiologia , Fármacos Dermatológicos/uso terapêutico , Administração Cutânea , Adolescente , Adulto , Quimioterapia Adjuvante , Criança , Pré-Escolar , Dermatite Atópica/tratamento farmacológico , Dermatite Atópica/patologia , Dermatite Atópica/fisiopatologia , Fármacos Dermatológicos/administração & dosagem , Progressão da Doença , Intervalo Livre de Doença , Feminino , Humanos , Lactente , Masculino , Prevalência , Adulto JovemRESUMO
Acne is one of the most common disorders treated by dermatologists and other health care providers. While it most often affects adolescents, it is not uncommon in adults and can also be seen in children. This evidence-based guideline addresses important clinical questions that arise in its management. Issues from grading of acne to the topical and systemic management of the disease are reviewed. Suggestions on use are provided based on available evidence.
Assuntos
Acne Vulgar/diagnóstico , Acne Vulgar/tratamento farmacológico , Antibacterianos/uso terapêutico , Fármacos Dermatológicos/uso terapêutico , Guias de Prática Clínica como Assunto , Administração Oral , Administração Tópica , Adolescente , Adulto , Medicina Baseada em Evidências , Feminino , Seguimentos , Humanos , Isotretinoína/uso terapêutico , Masculino , Recidiva , Medição de Risco , Resultado do Tratamento , Adulto JovemRESUMO
Consumers are increasingly interested in over-the-counter skin care products that can improve the appearance of photodamaged and aging skin. This 10-week, open-label, single- center study enrolled 25 subjects with mild to moderate hyperpigmentation and other clinical stigmata of cutaneous aging including fine lines, sallowness, lack of clarity, and wrinkling. Their mean age was 53.4±7.7 years. The test product contained retinol 0.5% in combination with niacinamide 4.4%, resveratrol 1%, and hexylresorcinol 1.1% in a moisturizing base. Subjects were provided a skin care regimen including a cleanser, hydrating serum, moisturizer, and an SPF 30 sunscreen for daily use. The test product was applied only at night.
The use of this skin brightening/anti-aging cosmeceutical was found to provide statistically significant improvements in all efficacy endpoints by study end. Fine lines, radiance, and smoothness were significantly improved as early as week 2 (P<.001). By week 4, hyperpigmentation, overall skin clarity, evenness of skin tone, and wrinkles showed statistically significant improvement compared to baseline. Mild retinoid dermatitis including flaking and redness occurred early in the study as reflected by tolerability scores. By week 10, subjects reported no stinging, itching, dryness, or tingling.
The results of this open-label clinical study suggest that a topical cream containing retinol 0.5% in combination with niacinamide, resveratrol, and hexylresorcinol is efficacious and tolerable for skin brightening/anti-aging when used with a complementary skin care regimen including SPF 30 sun protection.
J Drugs Dermatol. 2016;15(7):863-868.
Assuntos
Cosmecêuticos/administração & dosagem , Hexilresorcinol/administração & dosagem , Niacinamida/administração & dosagem , Envelhecimento da Pele/efeitos dos fármacos , Estilbenos/administração & dosagem , Vitamina A/administração & dosagem , Administração Cutânea , Cosmecêuticos/efeitos adversos , Combinação de Medicamentos , Toxidermias/diagnóstico , Toxidermias/etiologia , Feminino , Hexilresorcinol/efeitos adversos , Humanos , Pessoa de Meia-Idade , Niacinamida/efeitos adversos , Resveratrol , Envelhecimento da Pele/patologia , Higiene da Pele/métodos , Pigmentação da Pele/efeitos dos fármacos , Estilbenos/efeitos adversos , Inquéritos e Questionários , Resultado do Tratamento , Vitamina A/efeitos adversosRESUMO
Seborrheic keratosis (SK) is among the most common cutaneous lesions, affecting some 83 million Americans. Biologically benign, SK lesions do not require removal for medical reasons unless histologic confirmation of the clinical diagnosis is required or the lesions are traumatized and/or become symptomatic. These macular or popular pigmented lesions are often of cosmetic concern to patients. In addition, their natural history of gradually increasing in size, thickness, and/or pigmentation often serves as the impetus compelling patients to present to a dermatologist for evaluation and skin cancer screening; SK is diagnosed and managed primarily by dermatologists. Data regarding SK prevalence and management from a survey of 594 practicing, board-certified dermatologists are summarized herein: Dermatologists report they diagnose an average of 155 patients per month with SK. Among SK patients presenting to dermatologists, 33% have more than 15 SK lesions and 67% have 15 or fewer SK lesions. On average, dermatologists treat 43% of their SK patients to remove lesions. Cryosurgery is the most common removal method. Other commonly employed removal methods include shave excision, electrodessication, curettage or a combination of these. While these procedures can be used to remove SK lesions effectively, each has potential drawbacks and careful patient selection is required to optimize cosmetic results particularly in skin of color patients and patients with thick or numerous lesions. While there is great interest from both patients and providers in a topical non-invasive treatment for SK, no effective topical therapeutic agent has been developed, and this remains an area of unmet need.
Assuntos
Dermatologia/métodos , Ceratose Seborreica/patologia , Seleção de Pacientes , Criocirurgia/métodos , Curetagem/métodos , Humanos , Ceratose Seborreica/diagnóstico , Ceratose Seborreica/epidemiologia , Prevalência , Estados Unidos/epidemiologiaAssuntos
Acne Vulgar/tratamento farmacológico , Composição de Medicamentos/métodos , Sistemas de Liberação de Medicamentos/métodos , Ceratolíticos/administração & dosagem , Tretinoína/administração & dosagem , Ensaios Clínicos Fase III como Assunto , Preparações de Ação Retardada/administração & dosagem , Preparações de Ação Retardada/efeitos adversos , Emulsões , Folículo Piloso/efeitos dos fármacos , Folículo Piloso/ultraestrutura , Humanos , Ceratolíticos/efeitos adversos , Ceratolíticos/farmacocinética , Microesferas , Polipropilenos/química , Poliuretanos/química , Porosidade , Solubilidade , Resultado do Tratamento , Tretinoína/efeitos adversos , Tretinoína/farmacocinéticaRESUMO
Rosacea is a condition most commonly characterized by central facial erythema and pupulopustules. There are highly effective drugs, both oral and topical, for papulopustular disease. At the present time, consistently effective pharmacologic therapy for erythematotelangiectatic rosacea is lacking. Patients whose papulopustular disease has been adequately treated are often still bothered by central facial erythema for which there is no adequate treatment short of laser and light. We present a study utilizing a novel topical composition evaluated for its ability to reduce background erythema remaining after adequate care of papulopustular disease. Patient, investigator and photographic evidence of erythema reduction was seen in 24/25 patients in this 8-week study.
Assuntos
Fármacos Dermatológicos/uso terapêutico , Eritema/tratamento farmacológico , Rosácea/tratamento farmacológico , Administração Cutânea , Fármacos Dermatológicos/administração & dosagem , Eritema/etiologia , Feminino , Humanos , Masculino , Rosácea/patologia , Resultado do TratamentoRESUMO
BACKGROUND: The popularity of social media appears to be increasing the acceptance of cosmetic treatments, prompting more consumers to seek cosmetic treatments. As the estimated prevalence of acne vulgaris among adult women may be as high as 54%, acne is commonly observed among patients presenting for cosmetic treatments. Concomitant treatment of acne in the aesthetic patient population will improve overall clinical outcomes. AIMS: The goal of this work was to deliver a high-quality ethical and evidence-based educational program to physicians and adjunctive health care providers to advance patient care. METHODS: This paper is based on a webcam presentation with roundtable discussion by several notable experts in their field. RESULTS: A range of topical medications, injectable products, chemical peels, and energy-based devices are available for treating acne vulgaris. In most instances, these are compatible with rejuvenation procedures in the aesthetic patient. CONCLUSION: The growth of social media is raising awareness of aesthetic procedures and appears to be increasing the number of patients seeking aesthetic treatment. Educating patients about the importance of treating acne vulgaris can improve overall treatment outcomes. In most instances, the presence of acne is not a barrier to aesthetic care.
Assuntos
Acne Vulgar , Abrasão Química , Adulto , Humanos , Feminino , Acne Vulgar/terapia , Acne Vulgar/complicações , Abrasão Química/métodos , Dermabrasão , Resultado do Tratamento , EstéticaRESUMO
INTRODUCTION: Acne is a common, complex, multifactorial inflammatory skin disease associated with epidermal barrier dysfunction. Beginning in childhood, acne affects many adolescents and adults. Acne is associated with lower self-esteem, anxiety, and depression and may cause scars and pigmentary sequelae. The review explores the relationships between acne and the skin barrier function and discusses nuances in the prevention, treatment, and maintenance of acne and its impact on the skin barrier. METHODS: The advisors' previous publications addressed prescription and nonprescription pediatric acne treatment and skincare using cleansers, moisturizers, and a practical algorithm for treatment and maintenance, including skincare recommendations for pediatric acne patients and an algorithm for skin of color patients with acne. Before the meeting, literature was culled on the relationship between the skin barrier and acne and current best practices in acne, addressing prescription and nonprescription acne products and skincare as monotherapy, adjunctive, and maintenance treatment. RESULTS: After discussing 13 draft statements, the advisors applied the selected literature and drew from their clinical knowledge and experience, and agreed on five statements. The follicular epithelial barrier is directly involved with changes that occur during both comedogenesis and in stages of inflammation, especially with follicular rupture compromising the barrier's integrity. In acne-affected skin, sebaceous glands are larger, sebum excretion and filaggrin expression higher, and stratum corneum lipids are reduced. Educating patients and clinicians about inflammation's central role in acne and measures to reduce inflammation is essential. Skin irritation and xerosis from acne and treatments lead to poor treatment adherence. A skincare regimen should be included in the acne prevention, treatment, and maintenance care regimen and should be ongoing. Maintenance treatment with topical agents and skincare using gentle ceramide-containing cleansers and moisturizers is a recommended strategy after successfully controlling the disease. CONCLUSIONS: Epidermal barrier dysfunction contributes to acne exacerbation. Using the appropriate treatment and skincare helps to minimize irritation and inflammation, enhance treatment adherence, and improve patient outcomes.
RESUMO
The Global Alliance to Improve Outcomes in Acne published recommendations for the management of acne as a supplement to the Journal of the American Academy of Dermatology in 2003. The recommendations incorporated evidence-based strategies when possible and the collective clinical experience of the group when evidence was lacking. This update reviews new information about acne pathophysiology and treatment-such as lasers and light therapy-and relevant topics where published data were sparse in 2003 but are now available including combination therapy, revision of acne scarring, and maintenance therapy. The update also includes a new way of looking at acne as a chronic disease, a discussion of the changing role of antibiotics in acne management as a result of concerns about microbial resistance, and factors that affect adherence to acne treatments. Summary statements and recommendations are provided throughout the update along with an indication of the level of evidence that currently supports each finding. As in the original supplement, the authors have based recommendations on published evidence as much as possible.
Assuntos
Acne Vulgar/terapia , Acne Vulgar/etiologia , Administração Oral , Administração Tópica , Algoritmos , Antibacterianos/administração & dosagem , Doença Crônica , Resistência Microbiana a Medicamentos , Quimioterapia Combinada , Medicina Baseada em Evidências , Humanos , Queloide/terapia , Fototerapia , Retinoides/administração & dosagemRESUMO
Chemical peeling is a popular, relatively inexpensive, and generally safe method to refresh and rejuvenate skin. This review focuses on superficial chemical peels and their use in routine clinical practice. A wide variety of peels are available, utilizing various actives and concentrations, including a recently introduced salicylic acid derivative, beta-lipohydroxy acid, which has properties that may expand the clinical use of peels. Superficial peels can be used to enhance treatment within a variety of conditions, including acne, melasma, dyschromias, photodamage and actinic keratoses. In addition, peels can be combined with other in-office procedures to optimize outcomes and enhance patient satisfaction, and allow clinicians to tailor the treatment to individual patient's needs. Successful outcomes are based on a thorough understanding and application of correct chemical peel procedures, including history-taking, pretreatment, preparation, peel selection, patient communication and maintenance regimens.Used properly, the superficial chemical peel has the potential to fill an important therapeutic need in the treatment armamentarium of dermatologists and plastic surgeons.
Assuntos
Abrasão Química/métodos , Envelhecimento da Pele/efeitos dos fármacos , Dermatopatias/terapia , Abrasão Química/efeitos adversos , Ensaios Clínicos como Assunto , Humanos , Rejuvenescimento , Pele/efeitos dos fármacos , Pele/patologia , Dermatopatias/patologiaRESUMO
The constant exposure of the skin to oxidative stress results in damage to cellular DNA and cell membrane lipids and proteins. To combat this problem, the skin contains a number of antioxidants that protect against oxidative injury. However, these cutaneous antioxidants can be depleted by sun exposure and environmental insults, resulting in an overload of oxidation products. Thus, topical antioxidants that replenish the antioxidant capacity of the skin have the potential to prevent oxidative damage. A number of natural antioxidant ingredients also have anti-inflammatory properties, and can be used in the treatment of oxidative damage such as photoaging and perhaps even skin cancer. This article summarizes the active components, pharmacologic properties, and clinical effectiveness of a number of natural antioxidant ingredients including soy, feverfew, mushroom extracts, teas, Coffea arabica (CoffeeBerry), Pinus pinaster (Pycnogenol), and Polypodium leucotomos. Recent clinical trials suggest that these compounds have promising efficacy in the topical treatment of oxidative stress-induced dermatoses.
Assuntos
Antioxidantes/administração & dosagem , Estresse Oxidativo/efeitos dos fármacos , Envelhecimento da Pele/efeitos dos fármacos , Administração Tópica , Antioxidantes/farmacologia , Humanos , Naturologia , Pele/efeitos dos fármacos , Pele/metabolismoRESUMO
Therapeutic options for rosacea include topical agents, oral therapies, laser and light treatments, and surgical procedures. Topical therapies play a critical role in the treatment of patients with papulopustular rosacea and erythematotelangiectatic rosacea, and have the ability to effectively minimize certain manifestations of the disease, including papules, pustules, and erythema. The 3 primary agents for the topical treatment of rosacea are metronidazole, azelaic acid, and sodium sulfacetamide-sulfur. Each of these therapies is approved for the treatment of rosacea and has been validated by multiple studies. Additional topical therapies including benzoyl peroxide, clindamycin, retinoids, topical steroids, calcineurin inhibitors, and permethrin are not approved for the treatment of rosacea and play variable roles in the management of this condition.
Assuntos
Rosácea/tratamento farmacológico , Administração Tópica , Ácidos Dicarboxílicos/administração & dosagem , Humanos , Metronidazol/administração & dosagem , Sulfacetamida/administração & dosagemRESUMO
The aging population and a desire to maintain a youthful appearance have propelled the recent surge in the U.S. cosmeceuticals market. The rapidly growing number of products claiming to diminish fine lines and wrinkles, decrease redness, smooth texture, and fade discoloration has lead to much confusion and misinformation among dermatologists and consumers alike. Cosmeceuticals can be a useful adjunct to prescription medications and office procedures. Therefore, it behooves us as dermatologists to understand the science behind these products to better educate ourselves and our patients. We present an update of the following categories of cosmeceuticals: antioxidants, growth factors, peptides, anti-inflammatories/botanicals, polysaccharides, and pigment-lightening agents.
Assuntos
Técnicas Cosméticas , Fármacos Dermatológicos/uso terapêutico , Cosméticos , Humanos , Envelhecimento da Pele/efeitos dos fármacosRESUMO
In a survey commissioned by Core-Create, Inc, and conducted by Harris Interactive, 422 subjects in the United States with chronic dermatologic diseases provided feedback regarding information and recommendations provided to them by their dermatologist on the use of moisturizers and cleansers. In particular, the survey results revealed that there is widespread underuse of these products in patients with common cutaneous disorders. The vast majority of patients wish that their dermatologist would provide more information about moisturizers and cleansers; additionally, they would like their dermatologist to recommend a specific product for them to use. What's more, patients want to know if a moisturizer or cleanser will do more than merely provide symptomatic relief. Patient education was confirmed as a critical factor in promoting patient compliance as evidenced by the fact that subjects were 4 times more likely to follow their physician's direction when the role of the products was explained to them than when no explanation was provided. In addition, it was found that overall patient satisfaction with the care received from their dermatologist is driven by communication.